摘要
北京市生物医药产业近年来呈现稳步增长态势,但仍锁定在全球价值链底端。要突破这种“低端锁定”,一方面需要聚焦关键领域,探索新型研发模式,逐步提升新药研发能力;另一方面,应完善创新生态建设,有序完善外部产业布局,建立自主品牌。
In recent years, Beijing biopharmaceutical industry is experiencing a steady growth, but it is still locked at the bottom of the global value chain. To achieve breakthrough, on one hand, we should gradually increase R&D investment and explore new R&D models to improve the innovation capabilities of new drugs;on the other hand, we should modify the innovation ecosystem and industrial layout, and establish our own brands.
作者
陈健
陈志
CHEN Jian;CHEN Zhi(Chinese Academy of Science and Technology Development, Beijing 100038)
出处
《全球科技经济瞭望》
2019年第4期19-25,共7页
Global Science，Technology and Economy Outlook
基金
科技创新战略研究专项“新兴产业发展与‘创新政策3.0’研究”(ZLY201709)
关键词
北京
生物医药
全球价值链
Beijing
biopharmaceutical industry
global value chain
